MNOP: Mirror Neurons in Older Participants

Sponsor
University of Central Florida (Other)
Overall Status
Terminated
CT.gov ID
NCT03946709
Collaborator
(none)
14
1
3
14.4
1

Study Details

Study Description

Brief Summary

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Action Observation
N/A

Detailed Description

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to atrophic effects, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary activation, and cortical excitability and inhibition in older adults. Following a thorough familiarization visit, twenty-five men and women ≥60 years of age will complete three action observation sessions in a randomized, counterbalanced manner: 1) observation of very strong hand/wrist contractions, 2) observation of very weak hand/wrist contractions, and 3) a control condition. Maximal voluntary contractions (MVCs) of the wrist flexors will be performed before and after observation sessions. Percent voluntary activation will be determined via the interpolated twitch technique. Single-pulse transcranial magnetic stimulation (TMS) and electromyographic (EMG) recordings from the flexor carpi radialis and first dorsal interosseous will be used to quantify cortical excitability and inhibition, via motor evoked potential amplitude and silent period duration, respectively. The hypothesis of this study is that observation of strong muscle contractions will acutely increase muscle strength, and such changes will be facilitated by enhanced corticospinal excitability and decreased inhibition. In contrast, it is hypothesized that observation of very weak contractions will cause no such efforts or even acute muscle weakness. Collectively, we propose that manipulation of mirror neurons is a worthwhile strategy for clinicians hoping to induce neuromuscular adaptations in older adults, particularly in settings where movement of a joint is painful or infeasible (e.g., bedrest or immobilization).

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Mirror Neurons in Older Participants (Project MNOP): Acute Effects of Action Observation on Muscle Strength/Weakness and Neurophysiological Factors in Older Adults
Actual Study Start Date :
Dec 20, 2018
Actual Primary Completion Date :
Mar 1, 2020
Actual Study Completion Date :
Mar 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Muscle strength condition

Other: Action Observation
Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.

Other: Muscle weakness condition

Other: Action Observation
Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Muscle Strength [5 minutes]

    Isometric muscle strength of the non-dominant hand and wrist flexors will be assessed during maximal voluntary contractions (MVCs).

Secondary Outcome Measures

  1. Voluntary Activation [5 minutes]

    Percent voluntary activation will be quantified during the MVCs to determine each participant's ability to maximally activate their wrist flexor muscles voluntarily.

  2. Corticospinal excitability [5 minutes]

    Transcranial magnetic stimulation will be used to quantify corticospinal excitability throughout the study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy men and women ≥60 years of age
Exclusion Criteria:
  • Neuromuscular disease (e.g. Parkinson's, MS, ALS)

  • Metabolic disease (e.g. diabetes, thyroid disorder, metabolic syndrome)

  • Arthritis in the upper limbs (hands, arms, shoulders)

  • Trouble using or controlling one's muscles

  • History of cancer

  • History of stroke

  • History of heart attack

  • Use of an assistive walking device or other mobility aids

  • Physician mandated contraindication to exercise within the last 6 months

  • Epilepsy or history of convulsions/seizures

  • History of fainting or syncope

  • History of head trauma that was diagnosed as concussion or was associated with loss of consciousness

  • History of hearing problems or tinnitus

  • Cochlear implants

  • Implanted metal in the brain, skull, or elsewhere in the body

  • Implanted neurotransmitter

  • Cardiac pacemaker or intracardiac lines

  • Medication infusion device

  • Past problems with brain stimulation

  • Past problems with MRI

  • Use of muscle relaxants or benzodiazepines

  • Allergy to rubbing alcohol

  • Any other health related illnesses that would prohibit a participant from physical performance testing

  • Lack of transportation to and from the laboratory

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCF Neuromuscular Plasticity Laboratory Orlando Florida United States 32826

Sponsors and Collaborators

  • University of Central Florida

Investigators

  • Principal Investigator: Matt S. Stock, Ph.D., University of Central Florida

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Matt Stock, Assistant Professor, University of Central Florida
ClinicalTrials.gov Identifier:
NCT03946709
Other Study ID Numbers:
  • SBE-18-14657
First Posted:
May 13, 2019
Last Update Posted:
Jun 28, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2021